Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Apyx Medical (APYX) have performed compared to their sector so far this year.
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Acurx Pharmaceuticals, Inc. (ACXP) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.
Acurx Pharmaceuticals, Inc. is one of 892 individual stocks in the Medical sector. Collectively, these companies sit at #7 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Acurx Pharmaceuticals, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for ACXP's full-year earnings has moved 42.5% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Our latest available data shows that ACXP has returned about 56.2% since the start of the calendar year. Meanwhile, the Medical sector has returned an average of -3.7% on a year-to-date basis. This shows that Acurx Pharmaceuticals, Inc. is outperforming its peers so far this year.
Apyx Medical (APYX) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 3.7%.
The consensus estimate for Apyx Medical's current year EPS has increased 17.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Acurx Pharmaceuticals, Inc. belongs to the Medical - Biomedical and Genetics industry, which includes 436 individual stocks and currently sits at #145 in the Zacks Industry Rank. Stocks in this group have gained about 5.4% so far this year, so ACXP is performing better this group in terms of year-to-date returns.
In contrast, Apyx Medical falls under the Medical - Products industry. Currently, this industry has 78 stocks and is ranked #156. Since the beginning of the year, the industry has moved -14.1%.
Acurx Pharmaceuticals, Inc. and Apyx Medical could continue their solid performance, so investors interested in Medical stocks should continue to pay close attention to these stocks.
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.
SeeWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Join 500,000+ readers who start their day with Quartz.
By subscribing, you agree to our Terms of Service and Privacy Policy.
